Sanofi engages in the research, production, and distribution of pharmaceutical products. The company is headquartered in Paris, Ile-De-France and currently employs 84,587 full-time employees. The company went IPO on 2002-07-01. The firm focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Sanofi terlibat dalam penelitian, produksi, dan distribusi produk farmasi. Perusahaan berkantor pusat di Paris, Ile-De-France dan saat ini mempekerjakan 84.587 karyawan tetap. Perusahaan melakukan penawaran umum perdana (IPO) pada 1 Juli 2002. Perusahaan ini berfokus pada kebutuhan pasien dan terlibat dalam penelitian, pengembangan, manufaktur, dan pemasaran solusi terapeutik. Tiga segmen operasionalnya adalah: Farmasi, Perawatan Kesehatan Konsumen (CHC), dan Vaksin. Segmen Farmasi meliputi: Imunologi, Sklerosis Ganda / Neurologi, Onkologi, Penyakit Langka, Gangguan Darah Langka, Kardiovaskular, Diabetes, Produk Resep yang Ada. Segmen Vaksin mencakup, untuk semua wilayah geografis, operasi komersial Sanofi Pasteur, bersama dengan kegiatan penelitian, pengembangan, dan produksi yang didedikasikan untuk vaksin. Segmen CHC mencakup operasi komersial untuk produk Perawatan Kesehatan Konsumen Sanofi, bersama dengan kegiatan penelitian, pengembangan, dan produksi yang didedikasikan untuk produk tersebut. Produk-produk perusahaan yang dikembangkan dalam kolaborasi atau waralaba mencakup Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Sanofi

NVIDIA

Apple

Google

Microsoft

Amazon

Broadcom

Meta Platforms

Taiwan Semiconductor

Tesla

Berkshire Hathaway

Walmart

Eli Lilly

JPMorgan

Visa

Oracle

Exxon Mobil

MasterCard

Johnson & Johnson

Palantir

SPDR S&P500 ETF

ASML

Netflix

Bank of America

AbbVie

Costco

Alibaba

Home Depot

Procter & Gamble

Cisco

Vanguard Total Stock Market ETF

Chevron

Coca-Cola

General Electric

UnitedHealth Group

Wells Fargo

Caterpillar

Morgan Stanley

AstraZeneca

Micron Technology

Goldman Sachs

American Express

Toyota

Novartis

Salesforce

Merck

T-Mobile

Philip Morris

Raytheon Technologies

Royal Bank of Canada

McDonald's

Abbott

Applied Materials

Novo Nordisk

Shopify

Shell

Intuitive Surgical

Invesco QQQ Trust

Citigroup

Lam Research

PepsiCo

Intel

Uber

Disney

QUALCOMM

Intuit

Linde PLC

Blackstone

AT&T

ServiceNow

Amgen

Verizon

NextEra Energy

Charles Schwab

Sony

Booking Holdings

BlackRock

Accenture

Texas Instruments

Danaher

Arista Networks

Banco Santander

Boeing

S&P Global

Toronto-Dominion Bank

Gilead Sciences

Pfizer

Capital One

Adobe

Unilever

Boston Scientific

TotalEnergies

Union Pacific

Lowe's

Analog Devices

Sanofi Stock

About Sanofi

Key Statistics